210 related articles for article (PubMed ID: 9619159)
1. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.
Malison RT; Best SE; van Dyck CH; McCance EF; Wallace EA; Laruelle M; Baldwin RM; Seibyl JP; Price LH; Kosten TR; Innis RB
Am J Psychiatry; 1998 Jun; 155(6):832-4. PubMed ID: 9619159
[TBL] [Abstract][Full Text] [Related]
2. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
3. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
[TBL] [Abstract][Full Text] [Related]
4. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.
Malison RT; McDougle CJ; van Dyck CH; Scahill L; Baldwin RM; Seibyl JP; Price LH; Leckman JF; Innis RB
Am J Psychiatry; 1995 Sep; 152(9):1359-61. PubMed ID: 7653693
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
[TBL] [Abstract][Full Text] [Related]
7. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
[TBL] [Abstract][Full Text] [Related]
8. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
[TBL] [Abstract][Full Text] [Related]
9. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
[TBL] [Abstract][Full Text] [Related]
10. Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.
Tissingh G; Bergmans P; Booij J; Winogrodzka A; van Royen EA; Stoof JC; Wolters EC
J Neurol; 1998 Jan; 245(1):14-20. PubMed ID: 9457623
[TBL] [Abstract][Full Text] [Related]
11. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
12. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.
Innis RB; Seibyl JP; Scanley BE; Laruelle M; Abi-Dargham A; Wallace E; Baldwin RM; Zea-Ponce Y; Zoghbi S; Wang S
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11965-9. PubMed ID: 8265656
[TBL] [Abstract][Full Text] [Related]
13. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients.
Jacobsen LK; Staley JK; Malison RT; Zoghbi SS; Seibyl JP; Kosten TR; Innis RB
Am J Psychiatry; 2000 Jul; 157(7):1134-40. PubMed ID: 10873923
[TBL] [Abstract][Full Text] [Related]
14. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
[TBL] [Abstract][Full Text] [Related]
15. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
16. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE
J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210
[TBL] [Abstract][Full Text] [Related]
17. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.
Naumann M; Pirker W; Reiners K; Lange KW; Becker G; Brücke T
Mov Disord; 1998 Mar; 13(2):319-23. PubMed ID: 9539347
[TBL] [Abstract][Full Text] [Related]
18. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
[TBL] [Abstract][Full Text] [Related]
19. [123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls.
Tissingh G; Bergmans P; Booij J; Winogrodzka A; Stoof JC; Wolters EC; Van Royen EA
Eur J Nucl Med; 1997 Sep; 24(9):1171-4. PubMed ID: 9283113
[TBL] [Abstract][Full Text] [Related]
20. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.
van Dyck CH; Quinlan DM; Cretella LM; Staley JK; Malison RT; Baldwin RM; Seibyl JP; Innis RB
Am J Psychiatry; 2002 Feb; 159(2):309-12. PubMed ID: 11823278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
